NCT06809127 (FACE_REHAB_MEG) is a NA clinical trial of Behavioral tasks with MEG recording in Facial Palsy, sponsored by Institut National de la Santé Et de la Recherche Médicale, France.

Who is sponsoring NCT06809127?

NCT06809127 is sponsored by Institut National de la Santé Et de la Recherche Médicale, France.

What drugs are being tested in NCT06809127?

Interventions in NCT06809127: Behavioral tasks with MEG recording.

What condition does NCT06809127 study?

NCT06809127 studies Facial Palsy, Surgery.

Is NCT06809127 still recruiting?

NCT06809127 is currently completed. Last updated 26 January 2026.

Last reviewed 2026-01-26 · How we verify

NCT06809127: FACE_REHAB_MEG

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Brain Plasticity and Emotion Recognition in Patients With Facial Palsy Before & After Surgical Rehabilitation: MEG Study

Completed NA Last updated 26 January 2026

What this trial tests

NA trial testing Behavioral tasks with MEG recording in Facial Palsy in 16 participants. Completed in 27 February 2023.

Timeline

26 June 2017

Primary endpoint
27 February 2023

27 February 2023

Quick facts

Lead sponsor	Institut National de la Santé Et de la Recherche Médicale, France
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	16
Start date	26 June 2017
Primary completion	27 February 2023
Estimated completion	27 February 2023
Sites	1 location across France

Drugs / interventions tested

Behavioral tasks with MEG recording

Conditions studied

Facial Palsy — all drugs for Facial Palsy →
Surgery — all drugs for Surgery →

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France — full company profile →

Who can join

Adults 20 to 70, any sex, with Facial Palsy or Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Facial palsy (of one hemiface) affects the sensorimotor representation of the face of the patients, and possibly also their mental representation of emotional facial expressions. Three surgical techniques are performed to rehabilitate the face motricity in patients with severe facial palsy: Facio-facial anastomosis (AFF), Hypoglosso-facial anastomosis (AHF), and Lengthening temporalis myoplasty (LTM). Our objective is to study brain plasticity and facial emotion recognition in patients with facial palsy before and after surgical rehabilitation, using non invasive magnetoencephalography (MEG) recording during motor and emotion recognition tasks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Facial Palsy

Currently open trials in the same condition.

NCT07325604 — Effect of Neuromuscular Electrical Stimulation on Unilateral Central Facial Palsy · NA · recruiting
NCT06532903 — Functional Recovery From Facial Paralysis · NA · recruiting
NCT06579235 — Explorative Proteomics in Pediatric Neuroborreliosis · active not recruiting
NCT03781700 — Evaluation of Cortisone Treatment in Children With Acute Facial Nerve Palsy · Phase 4 · recruiting

Other Institut National de la Santé Et de la Recherche Médicale, France trials

Trials by the same sponsor.

NCT07311213 — GENES AND AUTISM - IPSC · NA · not yet recruiting
NCT07063719 — Identification of Cellular Biomarkers of Rare Eye Diseases in Adults · NA · not yet recruiting
NCT06906042 — Multimodal Cardiovascular and Hepatic Population Imaging · recruiting
NCT06951035 — Impact of rTMS on BCI Control in Upper Limb Motor Rehabilitation of Patients With Chronic Stroke · NA · not yet recruiting
NCT06660108 — MOLECULAR BASIS OF LANGUAGE DEVELOPMENT AND ASSOCIATED DISORDERS · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06809127 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Institut National de la Santé Et de la Recherche Médicale, France
Last refreshed: 26 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06809127.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing